Alembic Limited announced that Mr. C. P. Buch has completed his second consecutive term of five years as an Independent Director and consequently ceases to be a Director of the Company with effect from end of the day on 31st March, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
99.69 INR | +0.66% | +11.18% | +9.30% |
May. 13 | Alembic Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
May. 09 | Alembic Pharmaceuticals' Consolidated Net Profit Jumps in Fiscal Q4 | MT |
1st Jan change | Capi. | |
---|---|---|
+9.30% | 310M | |
+14.82% | 28.11B | |
-6.39% | 27.28B | |
+25.01% | 26.41B | |
+13.66% | 24.87B | |
+42.38% | 22.93B | |
+15.26% | 21.18B | |
-0.38% | 19.18B | |
+23.27% | 16.19B | |
-9.57% | 15.82B |
- Stock Market
- Equities
- ALEMBICLTD Stock
- News Alembic Limited
- Alembic Limited Announces Cessation of C. P. Buch as an Independent Director